Your browser is no longer supported. Please, upgrade your browser.
Settings
ORMP Oramed Pharmaceuticals Inc. daily Stock Chart
ORMP [NASD]
Oramed Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-0.95 Insider Own2.10% Shs Outstand13.10M Perf Week1.90%
Market Cap112.14M Forward P/E- EPS next Y-1.27 Insider Trans0.00% Shs Float9.64M Perf Month13.48%
Income-12.50M PEG- EPS next Q-0.28 Inst Own10.10% Short Float2.27% Perf Quarter30.49%
Sales2.20M P/S50.97 EPS this Y-29.90% Inst Trans-0.08% Short Ratio4.74 Perf Half Y37.62%
Book/sh1.49 P/B5.74 EPS next Y-29.60% ROA-29.60% Target Price25.00 Perf Year5.68%
Cash/sh2.00 P/C4.28 EPS next 5Y- ROE-55.00% 52W Range5.70 - 8.94 Perf YTD39.87%
Dividend- P/FCF37.38 EPS past 5Y-24.70% ROI-43.30% 52W High-4.25% Beta1.15
Dividend %- Quick Ratio5.20 Sales past 5Y- Gross Margin69.10% 52W Low50.18% ATR0.32
Employees12 Current Ratio5.20 Sales Q/Q200.00% Oper. Margin- RSI (14)58.64 Volatility3.09% 4.55%
OptionableYes Debt/Eq0.00 EPS Q/Q2.90% Profit Margin- Rel Volume0.41 Prev Close8.58
ShortableYes LT Debt/Eq0.00 EarningsJul 05 Payout- Avg Volume46.23K Price8.56
Recom2.00 SMA206.09% SMA506.43% SMA20024.80% Volume18,816 Change-0.23%
May-26-16Reiterated FBR Capital Outperform $15 → $20
Dec-01-15Reiterated H.C. Wainwright Buy $24 → $25
Nov-19-15Initiated FBR Capital Outperform $15
Apr-13-15Resumed MLV & Co Buy $27 → $30
Jan-30-14Reiterated Aegis Capital Buy $30 → $35
Jan-08-14Reiterated Aegis Capital Buy $25 → $30
Jan-08-14Initiated MLV & Co Buy $27
Dec-03-13Initiated Aegis Capital Buy $25
Jul-18-17 08:50AM  Oramed Appoints Dr. Simon Bruce as Vice President of Medical Affairs PR Newswire
Jul-12-17 08:50AM  Oramed to Present at BIT'S 5th World Congress of Diabetes on July 13, 2017 PR Newswire
Jul-11-17 08:50AM  Oramed Announces End-of-Phase 2 Meeting with FDA to Initiate Phase 3 Program PR Newswire
Jul-10-17 10:57AM  Oramed Pharmaceuticals, Inc. :ORMP-US: Earnings Analysis: Q3, 2017 By the Numbers : July 10, 2017 Capital Cube
Jul-06-17 07:16PM  Oramed reports 3Q loss Associated Press
Jul-05-17 08:50AM  Oramed Announces Dual-Listing on Tel Aviv Stock Exchange PR Newswire +8.46%
Jun-27-17 08:45AM  Oramed Granted Japanese Patent for Combination Insulin and GLP-1 Analog Capsule PR Newswire +7.02%
Jun-12-17 08:17AM  Oramed Plans Secondary Listing in Tel Aviv Soon, CEO Kidron Says Bloomberg
Jun-06-17 08:45AM  Oramed to Present at the American Diabetes Association 77th Scientific Sessions PR Newswire
Jun-05-17 10:09AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Oramed Pharmaceuticals Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
May-18-17 08:45AM  Oramed to Present at Conferences Next Week PR Newswire
May-09-17 08:45AM  Oramed Granted Canadian Patent for GLP-1 Analog Capsule PR Newswire
May-05-17 10:24AM  Oramed Pharmaceuticals, Inc. :ORMP-US: Earnings Analysis: Q2, 2017 By the Numbers : May 5, 2017 Capital Cube
May-02-17 01:00PM  Oramed (ORMP) to Conduct Human Study for New Oral Leptin Capsule Zacks Small Cap Research
08:45AM  Oramed Receives Israel Regulatory Approval to Conduct Human Study for New Oral Leptin Capsule PR Newswire
May-01-17 01:40PM  Oramed Gaining Strength in Oral Diabetes Market GuruFocus.com
Apr-20-17 08:30AM  Oramed Granted European Patent for Combination Oral Insulin and GLP-1 Analog Capsule PR Newswire
Apr-06-17 05:01AM  Oramed reports 2Q loss Associated Press
Apr-04-17 08:45AM  Journal of Diabetes Science and Technology Publishes Scientific Paper Authored by Oramed Scientists PR Newswire
Mar-22-17 08:45AM  Oramed to Present at Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference on March 28, 2017 PR Newswire
Mar-21-17 09:28AM  ORAMED PHARMACEUTICALS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:45AM  Oramed Appoints Dr. Ronald Law as Chief Strategy Officer PR Newswire
Feb-09-17 05:16PM  While Big Diabetes Stagnates, Smaller Companies Are Moving Faster Than Ever GuruFocus.com
Feb-07-17 08:30AM  Oramed to Present at BIO CEO and Investor and Disruptive Growth and Healthcare Conferences PR Newswire
Jan-18-17 01:04PM  ORAMED PHARMACEUTICALS INC. Financials
Jan-12-17 05:00AM  Oramed reports 1Q loss
Jan-11-17 05:20PM  ORAMED PHARMACEUTICALS INC. Files SEC form 10-Q, Quarterly Report
Dec-30-16 11:15AM  3 Sleeper Biotechs That Could Bounce Back Strong in 2017 24/7 Wall St.
Dec-23-16 12:41PM  Something Strange Is Going On With Oral Insulin GuruFocus.com
Nov-30-16 02:15PM  ORMP: Oramed Reports Positive Phase Ib Data for ORMD-0901 Zacks Small Cap Research
Nov-29-16 08:30AM  Oramed's ORMD-0901 (Oral GLP-1 Analog) Found Safe and Well Tolerated in Phase Ib Study PR Newswire
Nov-25-16 11:17AM  ORAMED PHARMACEUTICALS INC. Files SEC form 10-K, Annual Report
Oct-06-16 08:45AM  Oramed Receives Additional $4 Million Milestone Payment From HTIT PR Newswire
Sep-19-16 09:00AM  Oramed to Present at the Aegis Capital Growth Conference PR Newswire
Sep-09-16 01:50PM  Inside The FDA: Eli Lilly and Co (LLY) Jardiance Aims at Proving Cardiovascular Benefit in Diabetes, Will FDA Agree? at Insider Monkey
Sep-07-16 08:00AM  Oramed to Present at the Rodman & Renshaw Global Investment Conference PR Newswire
Sep-06-16 01:38PM  Inside the FDA: Why Sanofi SA (ADR) (SNY) IGlarLixi Was Delayed But Novo Nordisk A/S (ADR) (NVO) IDegLira Wasnt at Insider Monkey
Aug-31-16 04:25PM  ORAMED PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a
Aug-26-16 08:20AM  Sanofi Just Cant Catch a Break, Knocking at Major Support Again at 24/7 Wall St.
Aug-11-16 11:30AM  Oramed (ORMP) Reports Additional Positive Data from Phase IIb ORMD-0801 Study
Aug-09-16 12:12PM  The Cryptic World of Oral Insulin, Novo Nordisk A/S (ADR) (NVO) vs Oramed Pharmaceuticals, Inc. (ORMP) at Insider Monkey
Aug-05-16 12:35PM  ORAMED PHARMACEUTICALS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
05:20AM  Novo's insulin pill shows promise in mid-stage trial
Aug-02-16 09:00AM  Oramed Receives Additional $4 Million Milestone Payment From HTIT PR Newswire
Jul-28-16 04:33PM  ORAMED PHARMACEUTICALS INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events
08:15AM  Oramed Reports Additional Phase IIb Oral Insulin Study Data Demonstrating Significant Lowering of Glucose Levels vs Placebo PR Newswire
Jul-27-16 10:15AM  ORAMED PHARMACEUTICALS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Jul-26-16 09:00AM  Oramed Appoints Dr. Roy Eldor as Chief Medical Director PR Newswire
Jul-06-16 04:58PM  Oramed reports 3Q loss
03:35PM  ORAMED PHARMACEUTICALS INC. Files SEC form 10-Q, Quarterly Report
Jun-22-16 12:20PM  The Top Four Diabetes Best Sellers and One Oral Insulin Pill That May Threaten Them All at Insider Monkey
Jun-21-16 09:05AM  Oramed Announces $6.5 Million Milestone Payment from HTIT PR Newswire
Jun-16-16 10:19AM  ORAMED PHARMACEUTICALS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Jun-11-16 09:20AM  3 Biotechs That Just Announced Successful Phase 2 Trials at 24/7 Wall St.
Jun-09-16 08:15AM  Oramed to Present at the American Diabetes Association 76th Scientific Sessions PR Newswire +6.21%
May-23-16 05:14PM  ORAMED PHARMACEUTICALS INC. Files SEC form 8-K, Regulation FD Disclosure
May-18-16 03:00PM  ORMP: Oramed Announces Positive Top-Line Data from Phase IIb ORMD-0801 Study -7.97%
10:56AM  ORAMED PHARMACEUTICALS INC. Files SEC form 8-K, Other Events
09:23AM  Oramed's Phase IIb Oral Insulin Study Meets Primary Safety And Efficacy Endpoints
07:30AM  Oramed says oral insulin succeeds in midstage type 2 diabetes trial
07:25AM  Oramed Announces Positive Top-Line Results from Phase IIb Oral Insulin Study PR Newswire
May-16-16 09:49AM  Oramed to Present at Oppenheimer Annual Israeli Conference PR Newswire +27.60%
May-12-16 02:45PM  ORMP: Todays Decline In Share Price Not Justified -21.57%
May-11-16 08:15AM  Oramed Patent Being Granted in China for Oral Administration of Proteins PR Newswire
May-04-16 08:35AM  ORAMED PHARMACEUTICALS INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online +6.15%
Apr-28-16 08:15AM  Oramed to Present at PIONEERS 2016, Presented by Joseph Gunnar PR Newswire
Apr-12-16 08:15AM  Oramed Receives Patent Term Adjustment Extending the Term of Its U.S. Patent PR Newswire
Apr-07-16 11:30AM  ORMP: Update on Fiscal Second Quarter Financials
Apr-06-16 05:41PM  Oramed reports 2Q loss
03:30PM  ORAMED PHARMACEUTICALS INC. Files SEC form 10-Q, Quarterly Report
Apr-05-16 08:15AM  Oramed Completes Phase IIb Oral Insulin Study PR Newswire
Mar-29-16 07:10PM  Oramed Patent Granted in India for Oral Administration of Proteins at noodls +5.56%
08:15AM  Oramed Patent Granted in India for Oral Administration of Proteins PR Newswire
Feb-04-16 08:15AM  Oramed to Present at the BIO CEO & Investor Conference PR Newswire +8.48%
Jan-14-16 03:06PM  ORAMED PHARMACEUTICALS INC. Files SEC form 8-K, Regulation FD Disclosure
Jan-13-16 04:23PM  Oramed reports 1Q loss
01:12PM  ORAMED PHARMACEUTICALS INC. Files SEC form 10-Q, Quarterly Report
Jan-12-16 12:40PM  Oramed Pharma (ORMP): Great Potential for its Unique Protein Oral Delivery (POD) Platform
Jan-06-16 10:08AM  ORAMED PHARMACEUTICALS INC. Files SEC form 8-K, Regulation FD Disclosure
08:15AM  Oramed Pharmaceuticals' Shareholder Letter PR Newswire
Dec-29-15 08:15AM  Oramed Announces Closing of Licensing and Investment Deal with HTIT for Oral Insulin Capsule in China PR Newswire
Dec-28-15 04:33PM  ORAMED PHARMACEUTICALS INC. Files SEC form 8-K, Other Events
Dec-01-15 09:00AM  $50 Million Plus Royalties Deal Indicates Blockbuster Future for Oramed's Oral Insulin Accesswire
Nov-30-15 04:15PM  ORAMED PHARMACEUTICALS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equi +17.42%
10:32AM  Oramed Pharmaceuticals (ORMP) Stock Surges on $50 Million Chinese Licensing Deal at TheStreet
08:16AM  Oramed Signs up to $50 Million Licensing and Investment Agreements for Oral Insulin Capsule in China PR Newswire
07:51AM  Israel's Oramed gets $50 mln China licensing, investment deal Reuters
Nov-25-15 01:39PM  ORAMED PHARMACEUTICALS INC. Files SEC form 10-K, Annual Report
Nov-20-15 06:08AM  [$$] Oramed Could Double With Diabetes Blockbuster at Barrons.com +12.50%
Oct-26-15 05:04PM  ORAMED PHARMACEUTICALS INC. Files SEC form 8-K, Other Events +6.56%
Oct-15-15 03:51PM  ORAMED PHARMACEUTICALS INC. Files SEC form 8-K, Other Events
Oct-01-15 08:15AM  Oramed to Present at the Aegis Capital Growth Conference PR Newswire +6.40%
Sep-24-15 08:15AM  Oramed Patent Allowed in the US for Oral Administration of Proteins PR Newswire +14.53%
Sep-09-15 08:15AM  Oramed Completes Randomization of Over 50% of Patients in Phase IIb Oral Insulin Study PR Newswire
Sep-04-15 08:15AM  Oramed to Present at the Rodman & Renshaw Global Investment Conference PR Newswire
Sep-03-15 09:13AM  ORAMED PHARMACEUTICALS INC. Files SEC form 8-K, Other Events -6.31%
Aug-31-15 08:45AM  As Diabetes Becomes an Epidemic, Patients Seek the Best Treatment Options Accesswire
Aug-12-15 08:12AM  ORAMED PHARMACEUTICALS INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jul-21-15 08:00AM  Cell MedX Aiming to Change Diabetes Care Forever Accesswire
Jul-14-15 02:21PM  3 Stocks Under $10 to Trade for Breakouts at TheStreet
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. Its product portfolio includes ORMD-0801, an oral insulin capsule, which has completed Phase IIb clinical trials for the treatment of diabetes; and ORMD-0901, an analog for GLP-1 gastrointestinal hormone, which has completed Phase Ib clinical trials for the treatment of type 2 diabetes. The company operates primarily in Israel. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in Jerusalem, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Li XiaopengDirectorApr 19Buy6.3352,814334,313116,714Apr 19 05:05 PM
Kidron MiriamChief Scientific OfficerApr 19Sale6.3352,814334,31389,636Apr 19 05:01 PM